This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "er_protein_storage_disease#Hepatic Protein Aggregation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should substitute the disorder-specific stored protein and gene (SERPINA1/Z-AAT for alpha-1 antitrypsin deficiency, FGG for hepatic fibrinogen storage disease) while preserving the conserved ER-retention → ER stress → hepatocyte injury → stellate-cell-mediated fibrosis chain. Reduced circulating levels of the affected secretory protein (e.g., hypofibrinogenemia, low serum AAT) are a secondary loss-of-secretion consequence handled in the disorder entries, not in this hepatocyte-toxicity module. Evidence here is drawn from the prototypical Z-AAT exemplar; it documents the conserved cascade rather than any single disease. This misfolding-retention-polymerization cascade is distinct from tsr_o_glycosylation_quality_control, which stabilizes correctly folded TSR domains and selectively affects their secretion without requiring ER storage.
Hepatic Protein Aggregation
trigger
A mutant secretory protein misfolds during biogenesis in the hepatocyte and a large fraction (e.g., ~85% of Z-AAT in the PiZZ genotype) is retained within the endoplasmic reticulum rather than being secreted. The retained protein adopts ordered polymerized or aggregated conformations forming intracellular inclusions, leaving the circulating protein deficient while imposing a proteotoxic burden on the hepatocyte.
Downstream
-
ER Stress and Unfolded Protein Response
Intracellular accumulation of misfolded/polymerized protein imposes proteotoxic stress on the ER, activating ER stress responses.
Show evidence (2 references)
"These homozygous individuals synthesize large quantities of a1AT mutant Z protein in the liver, but the mutant protein folds improperly during biogenesis and approximately 85% of the molecules are retained within the hepatocytes rather than appropriately secreted."
Documents the prototypical ER-storage step (Z-AAT): biogenesis misfolding and ~85% hepatocyte ER retention of a mutant secretory protein, the conserved trigger of this module.
"Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1 antitrypsin (AAT) within hepatocytes, which limits its access to the circulation and exposes the lungs to protease-mediated tissue damage."
Confirms the conserved misfolding-and-intrahepatocyte-accumulation model, with reduced circulating protein as a secondary loss-of-secretion consequence.
ER Stress and Unfolded Protein Response
amplifier
Accumulation of misfolded and polymerized protein in the ER lumen imposes sustained proteotoxic stress, activating the unfolded protein response and ER-overload signaling. ER-associated degradation and autophagic clearance are progressively saturated, sustaining and amplifying the cellular stress state.
Downstream
-
Hepatocyte Injury
Sustained ER stress and saturation of degradative clearance drive hepatocyte death.
Show evidence (1 reference)
"This intracellular death cascade appears to involve ER stress, mitochondrial depolarization, and caspase cleavage, and is possibly linked to autophagy and redox injury."
Identifies ER stress as the proximal amplifying signal that couples retained-protein burden to the hepatocyte death cascade.
Hepatocyte Injury
effector
Sustained ER stress and the intracellular polymer burden trigger mitochondrial depolarization and caspase-mediated apoptosis, with saturation of autophagic clearance and redox injury, producing chronic hepatocyte death and compensatory regeneration.
Downstream
-
Stellate Cell Activation and Fibrosis
The chronic cycle of hepatocyte death and regeneration activates hepatic stellate cells and initiates fibrosis.
Show evidence (1 reference)
"This intracellular death cascade appears to involve ER stress, mitochondrial depolarization, and caspase cleavage, and is possibly linked to autophagy and redox injury."
Defines the hepatocyte death cascade (mitochondrial depolarization, caspase cleavage, autophagy, redox injury) driven by the retained protein, the conserved injury effector of this module.
Stellate Cell Activation and Fibrosis
central effector
The chronic cycle of hepatocyte death and compensatory regeneration activates quiescent hepatic stellate cells, which transdifferentiate into collagen-producing myofibroblasts under TGF-beta signaling. Progressive collagen deposition drives bridging fibrosis and cirrhosis. This terminal step conforms to the conserved fibrotic response: the hepatic stellate cell is the organ-specific substitution for the generic activated mesenchymal cell.
Show evidence (2 references)
"This chronic cycle of cell death and regeneration activates hepatic stellate cells and initiates the process of hepatic fibrosis."
Establishes hepatic stellate cell activation as the link between chronic hepatocyte injury and progressive fibrosis, the conserved terminal effector that conforms to fibrotic_response#Mesenchymal Cell Activation.
"Alpha-1 antitrypsin deficiency (AATD) is a relatively common, but under-recognized condition which manifests commonly with liver cirrhosis and emphysema."
Confirms cirrhosis as the clinical endpoint of the ER-storage hepatopathy in the prototypical exemplar; partial because the quote establishes the cirrhotic outcome without detailing the stellate-cell mechanism.